DLK Investment Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

DLK Investment Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.86K	Buy	+77,000	New	+$417K	﹤0.01%	96
2025 Q4	–	Sell	-164,477	Closed	-$49.3K	–	94
2025 Q3	$49.3K	Hold	164,477	–	–	0.02%	83
2025 Q2	$43.2K	Buy	164,477 +87,477	+114%	+$13K	0.02%	80
2025 Q1	$2.93K	Hold	77,000	–	–	﹤0.01%	87
2024 Q4	$13.9K	Hold	77,000	–	–	0.01%	88
2024 Q3	$10.8K	Hold	77,000	–	–	﹤0.01%	109
2024 Q2	$7.86K	Hold	77,000	–	–	﹤0.01%	105
2024 Q1	$14.1K	Hold	77,000	–	–	0.01%	101
2023 Q4	$25.4K	Buy	+77,000	New	+$34.4K	0.01%	98

Other funds holding RVMDW

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

DLK Investment Management's RVMDW Position: Q2 2026 in Review

DLK Investment Management opened a new position in Revolution Medicines Inc Warrant (RVMDW) in Q2 2026: 77,000 shares worth $7.86K. The stake represents ﹤0.01% of the portfolio and ranks #96 among its holdings. This is a return to the name: DLK Investment Management previously reported a position in RVMDW as recently as Q3 2025.

DLK Investment Management first reported a position in RVMDW in Q4 2023 and has held it in 9 quarters since. The position peaked at $49.3K in Q3 2025. 2 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

DLK Investment Management held 77,000 shares of Revolution Medicines Inc Warrant worth $7.86K as of Q2 2026.
Revolution Medicines Inc Warrant was a new DLK Investment Management position in Q2 2026.
Revolution Medicines Inc Warrant made up ﹤0.01% of DLK Investment Management's portfolio in Q2 2026, its #96 holding.
DLK Investment Management first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 9 quarters since.
DLK Investment Management's Revolution Medicines Inc Warrant position peaked at $49.3K in Q3 2025.
2 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on DLK Investment Management's 13F filing for Q2 2026, filed 14 Jul 2026.